Literature DB >> 8645226

Casein kinase 2 inhibits the renaturation of complementary DNA strands mediated by p53 protein.

O Filhol1, J Baudier, E M Chambaz, C Cochet.   

Abstract

Considerable effort is currently being devoted to understand the functions of protein p53, a major regulator of cell proliferation. The protein p53 has been reported to catalyse the annealing of complementary DNA or RNA strands. We report that this activity is inhibited in the presence of the serine/threonine protein kinase CK2. It is shown that this inhibition can be explained by the occurrence of a high-affinity molecular association between p53 and CK2. The molecular complex involves an interaction between the C-terminal domain of p53 and the beta subunit of the oligomeric kinase. Accordingly, the isolated alpha subunit of the kinase was without effect. In addition, after phosphorylation by CK2, phosphorylated p53 lost its DNA annealing activity. Because the C-terminal domain of p53 is both involved in the association with CK2 and phosphorylated by it, our results suggest that either protein-protein interaction or phosphorylation of this domain might control the base pairing of complementary sequences promoted by p53 in processes related to DNA replication and repair.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645226      PMCID: PMC1217343          DOI: 10.1042/bj3160331

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  The p53 proto-oncogene can act as a suppressor of transformation.

Authors:  C A Finlay; P W Hinds; A J Levine
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

Review 3.  p53 in Paris, an oncogene comes of age.

Authors:  D P Lane
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

4.  p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches.

Authors:  S Lee; B Elenbaas; A Levine; J Griffith
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

5.  Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.

Authors:  J Jayaraman; C Prives
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

6.  The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.

Authors:  M Reed; B Woelker; P Wang; Y Wang; M E Anderson; P Tegtmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

7.  Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo.

Authors:  S Jamal; E B Ziff
Journal:  Oncogene       Date:  1995-06-01       Impact factor: 9.867

Review 8.  Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation.

Authors:  J E Allende; C C Allende
Journal:  FASEB J       Date:  1995-03       Impact factor: 5.191

9.  p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1.

Authors:  D M Milne; L E Campbell; D G Campbell; D W Meek
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

10.  DNA binding properties of murine p53.

Authors:  K Steinmeyer; W Deppert
Journal:  Oncogene       Date:  1988-11       Impact factor: 9.867

View more
  7 in total

1.  Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

Authors:  L McKendrick; D Milne; D Meek
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 2.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 3.  Murine protein kinase CK2: gene and oncogene.

Authors:  X Xu; E Landesman-Bollag; P L Channavajhala; D C Seldin
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  Overlapping and divergent actions of estrogen and the neurotrophins on cell fate and p53-dependent signal transduction in conditionally immortalized cerebral cortical neuroblasts.

Authors:  S B Wade; P Oommen; W C Conner; D J Earnest; R C Miranda
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

5.  Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.

Authors:  M Hjerrild; D Milne; N Dumaz; T Hay; O G Issinger; D Meek
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 6.  Having it both ways: transcription factors that bind DNA and RNA.

Authors:  Laura A Cassiday; L James Maher
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

7.  The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteins.

Authors:  Zulfiqar F Cheema; Daniel R Santillano; Stephen B Wade; Joseph M Newman; Rajesh C Miranda
Journal:  BMC Neurosci       Date:  2004-03-23       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.